Company / Shareholders' Equity
Doximity Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.1B
FY2025
5-year range
$66.7M / $1.1B
FY2021-FY2025
Trend
+20.1%
vs FY2024
Sector context
#84 of 166
Health Care
What the data says
At $1.1B, Doximity's shareholders' equity ranks #84 of 166 in the Health Care sector. Improved from $966M to $1.1B over the past 2 years.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +294.3%.
Improved from $966M to $1.1B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +7.2%
- 5-Year CAGR
- +294.3%
- 10-Year CAGR
- -
Sector benchmark
#84 of 166 in Health CareTop 51% of 166This company $1.1B Sector average $5.3B
▼
-79.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +294.3%, indicating consistent growth.
- In FY2025, shareholders' equity increased 20.1% year-over-year.
- Ranks #84 out of 166 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +20.1% |
| FY2024 | $901.4M | -6.7% |
| FY2023 | $966.1M | +10.0% |
| FY2022 | $878.6M | +1216.4% |
| FY2021 | $66.7M | +5775.3% |
| FY2020 | $1.1M | +103.4% |
| FY2019 | -$32.9M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026